Jiangsu Hanbon Technology Co., Ltd., established in 1998, operates wholly-owned subsidiaries including Jiangsu Hedera Technology Co., Ltd., Jiangsu Hanphx Technology Co., Ltd., and HANBON (SINGAPORE) PTE. LTD. The company currently employs over 600 people and is recognized as a national high-tech enterprise and a specialized "Little Giant" enterprise with chromatography products at its core. The main products include equipment for the separation and purification of small molecule drugs, large molecule drugs, and laboratory instrument equipment. The company is capable of providing customers with services such as separation and purification process development, technical application, and customization of separation materials, as well as integrated solutions for pharmaceutical engineering separation and purification. The products and technologies of the company are widely applied in the research and production of drugs such as contrast agents, antibiotics, fish oil, natural products, peptides, insulin, antibodies, and vaccines. It has become a leading enterprise in the domestic chromatography separation and purification equipment industry, exporting products to many countries and regions around the world, and has gained a certain level of influence in the industry.
Year Established: 1998
Total Assets(USD): 500,000 to 99,999,999
Total Number of Staff: 100-500
Main Competitive Advantages: Brand Name,International Approvals/Standards,Experienced R&D Staff,Delivery Term,Production Capacity,Large Product Line,Buyers' Specifications Accepted,Small Orders Accepted,Reputation,Quality Service
Business Type: Service Provider,Manufacturer
R&D Capacity: Own Brand
Main Sales Markets : North America,Western Europe,Eastern Europe,Australasia,Asia
Subscribe to the latest newsletter of Virtual Expo Connect